Why Omeros Corporation’s (OMER) Stock Is Up 5.47%
As of Wednesday, August 19, Omeros Corporation’s OMER share price has surged by 5.47%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company’s lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company’s products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; OncotoX-AML, to treat acute myeloid leukemia; and Targeted Complement Activating Therapy, for Multidrug-resistant organisms. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.
Commentary & Analysis
Why Omeros Corporation’s (OMER) Stock Is Up 24.95%
As of Thursday, August 13, Omeros Corporation’s OMER share price has surged by 24.95%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Omeros Corporation’s (OMER) Stock Is Up 21.74%
As of Thursday, August 13, Omeros Corporation’s OMER share price has surged by 21.74%, which has investors questioning if this is right time to sell.Tudor Pop
Why Omeros Corporation’s (OMER) Stock Is Up 12.56%
As of Monday, July 27, Omeros Corporation’s OMER share price has surged by 12.56%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Omeros Corporation’s (OMER) Stock Is Up 14.30%
As of Monday, July 27, Omeros Corporation’s OMER share price has surged by 14.30%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | OMER | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,348.6 | $618.0 | 48% |
|
| Shares Out (Mil) | 89.6 | 44.8 | 60% |
|
| Institutional Ownership | 93.0% | 85.3% | 62% |
|
| Float (Mil) | 69.8 | 47.4 | 54% |
|
| Beta | 2.54 | 0.70 | 96% |
|
| Avg Daily Volume (000s) | 3,374 | 390 | 89% |
|
| Price Change (52-week) |
327.3% | 68.6% | 99% |
|
| Growth | OMER | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.7% | na |
|
| Net Income (5yr) | 52.3% | (1.6%) | 94% |
|
| EPS (5yr) | 53.4% | 14.9% | 94 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (5.1%) | (14.9%) | 61% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.025) | $0.660 | $1.145 | |
| Month Ago EPS | ($0.270) | $0.380 | ($0.155) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.197) | $0.423 | $0.540 | |
| Year/Year Chg | (131.3%) | (968.4%) | (2,574%) | |
| Financials | OMER | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $38 | $291 | 18% |
|
| Net Income (TTM) (Mil) | $125 | ($11) | 63% |
|
| EPS (TTM) | $1.774 | ($0.700) | 69% |
|
| Operating Cash Flow (TTM) (Mil) | ($69) | ($6) | 8% |
|
| Net Cash Flow (TTM) (Mil) | $0 | $5 | 43% |
|
| Long-Term Debt (Q1) (Mil) | $238 | $6 | 51% |
|
| Enterprise Value (Q1) (Mil) | $1,409 | $450 | 45% |
|
| Valuation | OMER | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.78 | na |
|
| P/E | 12.7 | 17.4 | 29% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.2 | 1.1 | 10% |
|
| Ratios | OMER | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 38.3% | 67.0% | 47% |
|
| Net Margin | 324.9% | (2.3%) | 100% |
|
| ROA | 51.2% | (22.4%) | 99% |
|
| ROE | (89.2%) | (20.2%) | 10% |
|
| Liabilities to Assets | 117.9% | 32.2% | 96% |
|
| F-Score | 3 | 3 | 18% |
|
Omeros Corporation did not pass any screens on 8/20/2026.
